85 results

• NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss

  July 10, 2025

  Irvin Jackson

  Novo Nordisk is facing a lawsuit alleging it failed to adequately warn about the risk of vision loss from Ozempic, including cases of NAION (non-arteritic anterior ischemic optic neuropathy).

• Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court

  June 18, 2025

  Irvin Jackson

  At least 21 Ozempic and Wegovy lawsuits have been filed in New Jersey state court, involving allegations that users were left with vision loss from NAION after using the popular diabetes and weight loss drugs.

• Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators

  June 9, 2025

  Irvin Jackson

  European regulators have determined that Ozempic and similar semaglutide-based drugs increase the risk of a rare vision disorder that can cause vision loss and blindness.

• Wegovy Lawsuit Alleges Vision Loss Side Effects Concealed by Novo Nordisk

  May 6, 2025

  Irvin Jackson

  A Wegovy lawsuit claims the weight loss drug's side effects caused him to suffer vision problems after a year of injections.

• More Than a Third of GLP-1 Drug Users Microdose To Avoid Side Effects, Survey Finds

  May 2, 2025

  Irvin Jackson

  Most users of Ozempic and similar drugs say they currently take microdoses of the medications or have done so in the past.

• Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects

  April 28, 2025

  Irvin Jackson

  A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye.

• Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks

  March 21, 2025

  Irvin Jackson

  Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs.

• GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing

  March 17, 2025

  Irvin Jackson

  Eli Lilly has filed a motion calling for a federal judge to put in place specific requirements for establishing a gastroparesis diagnosis in stomach paralysis lawsuits filed against the makers of Mounjaro, Ozempic and other GLP-1 medications.

• Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia

  March 12, 2025

  Irvin Jackson

  New findings appear to contradict warnings that GLP-1 drugs, like Ozempic and Mounjaro, can increase the risk of post-surgical aspiration due to a lack of gastric emptying.

• Victoza Caused Side Effects in 80% of Children, But Helped Them Lose Weight: Study

  February 12, 2025

  Irvin Jackson

  Most children given Victoza for about a year suffered gastrointestinal adverse events, according to a study that also concludes the drug could help some obese children significantly reduce their BMI.